However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook assesses the market drivers and resistors and predicts the effects of these. The report analyzes the overarching trends in the industry; examines which regions are set to see growth in CRO activity; evaluates the leading CROs; and outlines the future of the industry. The report provides insight into conditions into seven emerging regions including China, India and Latin America. It highlights the evolving business and relationship models between CROs and sponsor companies and enables optimal outsourcing strategy.

Key features of this report

Identifies and analyses the most recent trends and issues in outsourcing clinical R&D

Describes where clinical trials will be conducted in the future

Explores the complexities and the costs of outsourcing R&D to different world regions

Profiles the major international CRO players

Provides a detailed assessment of the current CRO market, including information on market shares and the size and growth of R & D expenditure

Focuses on emerging CRO markets

Highlights evolving strategies for working with CROs

Examined the current and future business models CRO

Key findings from this report

The total CRO market size is estimated at $20bn in 2008 and expected to grow at an annual rate of 8. 5% to reach $35bn through 2015. The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.

CROs provide substantial global capacity to drug developers and have become a critical contributor to clinical trial activity. Projects with high CRO involvement are associated with shorter development times.

Of the large, global contract research providers, Quintiles is market leader, with 15% of the global market share, followed by Covance and PPD. The five largest CROs have increased their market share and now hold 55% of the total market.

The leading CROs are commodity full service providers operating on a global scale. They act as one-stop shops for all services, from preclinical through marketing.

The number of clinical studies conducted in Asia, Central and Eastern Europe and Latin America is constantly rising. India and China are the future outsourcing destinations of choice.

CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive edge in the global business environment.     Table of Contents :  Executive summary The global contract research organization market CRO market analysis Established regions in the global CRO market Emerging regions in the global CRO market Leading players in the global CRO market The future of contract research Chapter 1 The global contract research organization market Summary Introduction The CRO contribution to drug development Market overview Key market drivers Key market restraints Conclusions and key findings Overview of the global CRO market Total revenue forecasts Global R&D expenditure and CRO market size Global clinical development outsourcing The contribution of CRO to drug development Current market drivers Growth of R&D expenditure from biotech and pharma Cost pressures encourage R&D outsourcing Long term growth and R&D expenditure of biotechnology companies Growing regulatory burden and safety concerns US EU Patient recruitment Increasing number of products in development The development of biomarkers Current market restraints Near term reductions in biotech R&D spending Growing competition and customer consolidation New financial realities alter biopharmaceutical outsourcing landscape Shortage of clinical research personnel Electronic data capture: a threat to CRO revenue Key market trends Globalization EDC evolution Strategic alliances Chapter 2 CRO market analysis Summary Introduction Market conditions Competitive analysis Market share analysis Competitive dynamics Academic medical centers Site management organizations Laboratory analytical services Non-CRO niche service providers Conclusion CRO service models Introduction The full service model SWOT analysis The niche model SWOT analysis Industry strategies Consolidation: Mergers & acquisitions in the CRO industry Expanding the continuum of services: vertical integration Forward integration Backward integration Industry challenges Consolidation within the CRO industry: a threat to close customer relationships Strategic outsourcing: demonstrating clear value to clients Co-development: sharing the risk Chapter 3 Established regions in the global CRO market Summary Introduction The US CRO market Overview Drivers of the US CRO market Challenges of the US CRO market Competitive dynamics The CRO market in Western Europe Overview Infrastructure and local regulations Drivers of the CRO market in Western Europe Challenges of the CRO market in Western Europe Competitive dynamics Chapter 4 Emerging regions in the global CRO market Summary Introduction The Central and Eastern European CRO market Overview Infrastructure and local regulations Benefits of outsourcing to CEE Challenges of outsourcing to CEE Competitive dynamics The CRO market in China Overview Infrastructure and local regulations Benefits of outsourcing to China Challenges of outsourcing to China Competitive dynamics The CRO market in India Overview Infrastructure and local regulations Intellectual property Legislative reforms Benefits of outsourcing to India Challenges of outsourcing to India Competitive dynamics The CRO market in Latin America Overview Infrastructure and local regulations Argentina Brazil Mexico Benefits of outsourcing to Latin America Challenges of outsourcing to Latin America Competitive dynamics The CRO markets in South Korea and Turkey Overview Infrastructure and local regulations Benefits of outsourcing to South Korea Challenges of outsourcing to South Korea Benefits of outsourcing to Turkey Challenges of outsourcing to Turkey Competitive dynamics Chapter 5 Leading players in the global CRO market Summary Introduction The client perspective Capabilities of leading CROs Quintiles Transnational Corp Company profile Business description Partnering collaborations and recent deals Covance Company profile Business description Partnering collaborations and recent deals PPD Inc. Company profile Business description Partnering collaborations and recent deals Charles River Laboratories Company Profile Business description Partnering collaborations and recent deals PAREXEL International Company profile Business description Partnering collaborations and recent deals ICON plc. Company profile Business description Partnering collaborations and recent deals MDS Inc Company profile Business description Partnering collaborations and recent deals Kendle International Company profile Business description Partnering collaborations and recent deals PRA International Company profile Business description Partnering collaborations and recent deals PharmaNet Development Group Company profile Business description Partnering collaborations and recent deals Chapter 6 The future of contract research Summary Introduction The shift towards a strategic model Emerging markets Phases I and IV growth activity Electronic data capture Biomarkers Selected acquisitions/partnerships Conclusion Key findings and conclusions Chapter 7 Appendix Selected bibliography Index List of Figures Figure 1. 1: Estimated CRO market ($bn), 2003-2015e Figure 1. 2: Global development expenditure and CRO market forecast ($bn), 2008-2014e Figure 1. 3: CRO usage and number of days by which projects overrun Figure 1. 4: Global pharmaceutical R&D expenditure ($bn), 2000-2014e Figure 1. 5: Number of FDA approvals 1990-2008 Figure 1. 6: Comparison of drug development cost estimates Figure 1. 7: Global biotech R&D expenditure ($bn), 2004-2012e Figure 1. 8: Number of products in development by phase 1998-2009 Figure 1. 9: CRO/Sponsor relationship models Figure 2. 10: Market share of major players, 2008 Figure 2. 11: Typical full service CRO model Figure 3. 12: R&D expenditures of PhRMA members and non-member companies ($bn), 1980- 2009 Figure 3. 13: Overall indexed clinical trial costs by region, 2006-2008 Figure 3. 14: The European CRO market – revenue forecast ($bn), 2008-2012e Figure 3. 15: Pharmaceutical R&D expenditure in Europe ($bn), 1990-2008 Figure 4. 16: Geographic distribution of clinical trials, 2005 to 2009f Figure 4. 17: Clinical trial costs of European countries compared to the UK Figure 4. 18: Comparison of trial registration periods in CEE countries (days) Figure 4. 19: CRO market in China ($m), 2007-2012e Figure 4. 20: China’s capabilities across the value chain Figure 4. 21: India’s capabilities across the value chain Figure 4. 22: Number of clinical trials in Latin America, 2000-2008 Figure 4. 23: Clinical trials in South Korea, 2005-2009e Figure 5. 24: Revenue growth of top public CROs in 2007-2008 Figure 5. 25: Capabilities of leading CROs, 2009 Figure 6. 26: Regional presence of major CROs Figure 6. 27: Attractiveness of selected countries for clinical trials Figure 6. 28: Global numbers of phase IV trials 2006-2009e Figure 6. 29: Electronic data capture market size ($m), 2006E-2012e Figure 6. 30: Clinical trials using predictive biomarkers, 2005-2009 List of Tables Table 1. 1: Functions commonly performed by CROs Table 2. 2: The global R&D outsourcing market: five major segments Table 2. 3: SWOT analysis: the full service model Table 2. 4: SWOT analysis: the niche model Table 2. 5: Key deals in the CRO sector Table 4. 6: Major CROs operating in Eastern Europe, 2009 Table 4. 7: Domestic Chinese CROs Table 4. 8: Major domestic CROs operating in Latin America, 2009 Table 4. 9: Selected domestic CROs in South Korea and Turkey Table 5. 10: Revenues ($m) and growth of major CROs, 2007-2008   

For More information please contact :

http://www. aarkstore. com/reports/The-CRO-Market-Outlook-Emerging-markets-leading-players-and-future-trends-34933. html


Article Source:China Sourcing Blog

Popularity: unranked [?]